Get more replies from employers
Send a job-specific resume in minutes.
Artiva Biotherapeutics Inc. in San Diego is seeking an Associate Scientist, Process Development Analytics to perform analytical testing in support of off-the-shelf NK cell therapies. You'll work with the Analytical and Process Development teams to transfer and conduct characterization testing.
Candidates should have strong experience in multi-parameter analytical assays, data interpretation, and documentation in a regulated GxP biotech setting; cell therapy experience is highly valued.
We are a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies. Our mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases. We aim to develop therapies that patients and physicians can utilize in a community setting. Our lead product candidate, AlloNK® , is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs). We believe the compelling cell killing properties of NK cells, when combined with mAbs for targeting, creates an opportunity to generate potentially transformative therapies.
For more information, visit www.artivabio.com.
Associate Scientist, Process Development Analytics will be responsible for
completing analytical testing in support of the development of off-the-shelf, allogeneic, natural killer (NK) cell-based therapies. Operating in a cross-functional and dynamic environment, the individual will work closely with the Analytical and Process Development team to transfer an and conduct characterization testing to support Process Development activities. The ideal candidate should have a proven track record of conducting analytical testing for cell therapy products.
In addition to a great culture, we offer:
If all this speaks to you, come join us on our journey!
Base Salary: $ 112,000 - .$129,000 annually. Exact compensation may vary based on level, skills and experience.